S&CO INC has recently submitted its 13F-HR report for the third quarter of 2026, revealing a total investment value of approximately $1.77 million as of September 30, 2026. This filing is significant as it provides insights into the company’s investment strategies and highlights its positions in major market players.

The report shows that S&CO INC has made substantial investments in well-known companies, including 3M Company, Abbott Laboratories, and Apple Inc. These holdings indicate the firm’s focus on established entities with strong market presences.

Background

S&CO INC is based in Boston, Massachusetts, and is classified under the SEC as an investment management firm. The company has consistently filed its 13F-HR reports, with the latest submission dated November 10, 2026. The firm’s Central Index Key (CIK) is 0001082461, and its fiscal year ends on December 31.

What the Filing Says

The latest 13F-HR report indicates that S&CO INC holds a total of 221 positions, with a combined value of $1,768,800. The filing states, "The report type is 13F HOLDINGS REPORT," which is standard for investment management firms to disclose their holdings to the SEC.

Impact

This filing may affect various stakeholders, including investors, analysts, and competitors in the investment management sector. By revealing its investment strategies, S&CO INC provides insights that could influence market perceptions and strategies of other firms in the industry.

What's Next

The filing does not say what happens next. However, it is expected that S&CO INC will continue to monitor and adjust its investment portfolio in response to market conditions and performance metrics.